Marshall Wace’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $583K | Buy |
+24,980
| New | +$583K | ﹤0.01% | 1961 |
|
|
2023
Q3 | – | Sell |
-3,698
| Closed | -$377K | – | 2424 |
|
|
2023
Q2 | $377K | Buy |
+3,698
| New | +$377K | ﹤0.01% | 1666 |
|
|
2021
Q2 | – | Sell |
-1,781
| Closed | -$1.39M | – | 2649 |
|
|
2021
Q1 | $1.39M | Buy |
+1,781
| New | +$1.39M | 0.01% | 1273 |
|
|
2020
Q4 | – | Sell |
-432
| Closed | -$198K | – | 2114 |
|
|
2020
Q3 | $198K | Sell |
432
-1,458
| -77% | -$668K | ﹤0.01% | 1420 |
|
|
2020
Q2 | $1.16M | Buy |
+1,890
| New | +$1.16M | 0.01% | 927 |
|
|
2019
Q1 | – | Sell |
-9,167
| Closed | -$4.29M | – | 2092 |
|
|
2018
Q4 | $4.29M | Sell |
9,167
-3,342
| -27% | -$1.56M | 0.04% | 488 |
|
|
2018
Q3 | $10.8M | Buy |
12,509
+2,817
| +29% | +$2.43M | 0.09% | 288 |
|
|
2018
Q2 | $6.68M | Buy |
+9,692
| New | +$6.68M | 0.1% | 237 |
|